Blood transfusion risks and alternative strategies in pediatric patients.
about
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusionRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseLeukoreduction for the prevention of adverse reactions from allogeneic blood transfusionCoagulopathy and transfusion therapy in pediatric liver transplantationPattern, indications and review of complications of neonatal blood transfusion in ibadan, southwest Nigeria.Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM(®) -assisted strategy - feasibility and costsIntraoperative optimization to decrease postoperative PRBC transfusion in children undergoing craniofacial reconstruction.The efficacy and cost-effectiveness of cell saver use in instrumented posterior correction and fusion surgery for scoliosis in school-aged children and adolescents.Risk factors for complications and readmission after operative fixation of pediatric femur fracturesTransfusion and risk of infection in Canada: Update 2012.Descriptions of acute transfusion reactions in the teaching hospitals of kermanshah university of medical sciences, iranAnesthesia for surgery related to craniosynostosis: a review. Part 2.Transfusion in critically ill children: an ongoing dilemma.Bleeding management for pediatric craniotomies and craniofacial surgery.Use of blood-sparing surgical techniques and transfusion algorithms: association with decreased blood administration in children undergoing primary open craniosynostosis repair.Postoperative complications in cirrhotic pediatric deceased donor liver transplantation: Focus on transfusion therapy.Risk factors for intraoperative allogeneic blood transfusion during craniotomy for brain tumor removal in children.Multiple Approaches to Minimize Transfusions for Pediatric Patients in Open-Heart Surgery.Association of Hematocrit and Red Blood Cell Transfusion with Outcomes in Infants Undergoing Norwood Operation.Factors influencing blood loss and allogeneic blood transfusion practice in craniosynostosis surgery.Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.Cerebral oximetry monitoring during preoperative phlebotomy to limit allogeneic blood use in patients undergoing cardiac surgery.Severe pediatric blunt trauma--successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets.Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices.Pulse Pressure Analysis to Guide Intraoperative Phlebotomy Prior to Cardiac Surgery.Blood transfusion in the surgical treatment of adolescent idiopathic scoliosis-a single-center experience of patient blood management in 210 cases.The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation.Assessment of cerebral oxygenation using near infrared spectroscopy during isovolemic hemodilution in pediatric patients.An evaluation of the mixed pediatric unit for blood loss replacement in pediatric craniofacial surgery.Preoperative risk factors for intra-operative bleeding in pediatric liver transplantation.Thromboelastometry during intraoperative transfusion of fresh frozen plasma in pediatric neurosurgery.Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.Application of mutant JAK2V617F for in vitro generation of red blood cells.Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion.Economic evaluation of cell salvage in pediatric surgery.Les transfusions et le risque d’infection au Canada : mise à jour pour 2012.
P2860
Q24187243-1D10846E-0188-4A25-BFAF-AB1324986592Q24200508-7037253D-74EB-495E-86C3-150C39C971C8Q24201453-2034D384-CDF3-43D2-AFC3-C0BC4A850672Q24201602-0283A072-48BA-44CC-B6CF-019938925A03Q26766108-08CB3438-1C41-44D2-90B0-379DBD0F35F2Q33950284-A497E8DC-2ECD-42E4-BF81-E8F4340120C0Q34392304-8F862FA7-BC93-4DBC-976E-909000006C3CQ35020041-3A82FA4E-C52A-4003-9F27-7E3A53732DA5Q35137499-99D70F31-8607-4C9E-AE57-FB817C74608CQ35995794-E9A422DE-9582-445B-B7BE-3422F2259403Q36547648-48DCA4C2-F283-483F-9975-0BCAC80F5A12Q37552707-FDD450D4-6031-4075-B7A1-95E78F814F08Q38033689-CC819CAA-3271-48A0-8A14-B73A7FEFE6E5Q38108382-63044DC3-F06D-43D5-B289-DDC9350ADA50Q38210761-77353C2A-C078-4EF4-8CF2-9D9296B82D9AQ38413361-CD3ADC0A-04DB-473A-B328-604700850865Q38691668-A3547AFE-4C3D-44F7-8966-98760879FB02Q40316436-1AB247A2-C6D8-4852-9020-DFCD98CE5D79Q40702911-BE456B9B-AE87-4090-8959-0E060184A5D2Q41216261-5FE05263-1696-413D-8AF1-2C71489E5CA2Q42616396-C5F68508-6625-47F2-9D38-A459CA68BDEEQ42678381-603AB520-B19C-42FD-ABB6-18F94CC8D439Q46562686-39FE3BDF-4DB9-4682-9C9A-8E4FA21D136AQ46738555-7048ED2C-1E88-4D6A-9CD8-664A6BA94571Q46836674-C7BC392E-4B5B-4CE4-87D9-A42E51827792Q47213545-777ACB34-39F4-407E-8A6B-892512EB74D1Q48149090-12CCFB8E-2480-4DD9-BA85-4A2F026DB34BQ48177340-05CB3B4C-85EC-4EA3-BC74-0054E0938E02Q48235895-AB8E4D71-E0AB-413C-8772-B6BBFA9FACB2Q48242471-0BE48AA1-28D2-400F-8958-3786EED10A7CQ48331152-647ACE55-BF1D-4672-87CF-DAF7E51584DFQ48528888-24FB9D7A-0F46-4B6B-A050-5A2897D00186Q50266154-263CAC26-BD16-4125-9965-C2E289E82CAAQ50276743-01C4A27A-DA81-4EE2-8DF1-71A32C17C2ADQ50472715-5B5566FE-F2A9-4AAB-B92E-7B7104890AB9Q50487257-980C5AB8-1EB8-4649-BF9F-53C9FC363716Q55077149-1722A738-1182-4D32-95E2-C8AEEF28E109
P2860
Blood transfusion risks and alternative strategies in pediatric patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood transfusion risks and alternative strategies in pediatric patients.
@en
Blood transfusion risks and alternative strategies in pediatric patients.
@nl
type
label
Blood transfusion risks and alternative strategies in pediatric patients.
@en
Blood transfusion risks and alternative strategies in pediatric patients.
@nl
prefLabel
Blood transfusion risks and alternative strategies in pediatric patients.
@en
Blood transfusion risks and alternative strategies in pediatric patients.
@nl
P2860
P1476
Blood transfusion risks and alternative strategies in pediatric patients.
@en
P2093
Josée Lavoie
P2860
P356
10.1111/J.1460-9592.2010.03470.X
P577
2011-01-01T00:00:00Z